Evaluation and monitoring of the National Drug Strategy 2004-2009
This report evaluates the National Drug Strategy (NDS) as a policy framework, the outcomes of programs under the NDS, and the roles and workings of the advisory structures that inform development and implementation of the NDS. It also monitors performance of the NDS during the period 2006-2009.
The report is in three parts:
Volume 1: findings and recommendations
Volume 2: case studies, literature reviews, and headline indicators
Page currency, Latest update: April, 2009